45.80
0.07%
-0.03
Handel nachbörslich:
45.80
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt HROW?
Forum
Prognose
Aktiensplit
Finanzdaten der Harrow Inc-Aktie (HROW)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
Revenues |
4.86%
34.59
|
36.35 | 34.27 | 33.47 | 26.10 |
Cost Of Revenue |
6.63%
10.55
|
11.30 | 10.07 | 10.00 | 8.271 |
Gross Profit |
4.07%
24.03
|
25.05 | 24.20 | 23.47 | 17.83 |
Operating Expenses
|
3.45%
30.96
|
29.93 | 22.45 | 21.12 | 16.62 |
Interest Income/Expense |
5.68%
5.415
|
5.124 | 5.749 | 5.704 | 4.747 |
Benefits Costs and Expenses |
4.59%
48.15
|
46.04 | 37.12 | 37.71 | 33.03 |
Costs And Expenses |
4.59%
48.15
|
46.04 | 37.12 | 37.71 | 33.03 |
Depreciation and Amortization |
0.69%
0.432
|
0.435 | 0.405 | 0.398 | 0.292 |
Operating Income/Loss |
42.11%
-6.928
|
-4.875 | 1.744 | 2.352 | 1.21 |
Nonoperating Income/Loss |
38.04%
-6.637
|
-4.808 | -4.596 | -6.596 | -8.141 |
Income/Loss From Continuing Operations Before Tax |
40.09%
-13.56
|
-9.683 | -2.852 | -4.244 | -6.931 |
Income/Loss From Continuing Operations After Tax |
48.28%
-13.56
|
-9.148 | -4.391 | -4.229 | -6.931 |
Net Income/Loss
|
48.28%
-13.56
|
-9.148 | -4.391 | -4.229 | -6.643 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
3,727%
35.47
|
0.9268 | 34.26 | 30.46 | 30.29 |
Diluted Average Shares |
3,727%
35.47
|
0.9268 | 34.26 | 30.46 | 30.29 |
Basic Earnings Per Share |
40.74%
-0.38
|
-0.27 | -0.13 | -0.14 | -0.22 |
Diluted Earnings Per Share |
40.74%
-0.38
|
-0.27 | -0.13 | -0.14 | -0.22 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Kapitalisierung:
|
Volumen (24h):